Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 26, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 7, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,4756 flagged findings
Reported transactions (Form 4)80since May 20, 2025 · and 19 other holdings
Corporate events (8-K)30since Aug 31, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Identity
Formerly traded as CBIO.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-08-07share offering or dilution eventfreshOpen filing ↗“…ATM Program On November 27, 2024, the Company entered into an Open Market Sale Agreement (the “ATM Agreement”) with Jefferies LLC…”
+1 more passage from the same document
- “…measurement between Level 1 and Level 2 and no transfers into or out of Level 3 for both financial assets and liabilities. Warrant…”
- 2026-08-07merger or acquisition eventfreshOpen filing ↗“…small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis.…”
+1 more passage from the same document
- “…drugs targeting organ diseases, focusing specifically on organ fibrosis. Fibrotic diseases represent a large patient population with…”
- 2022-05-02share offering or dilution eventstaleOpen filing ↗“…stock outstanding at March 31, 2022. We have determined beneficial ownership in accordance with SEC rules. The information does not…”
+1 more passage from the same document
- “…deemed outstanding includes shares issuable upon exercise of options or warrants, or the conversion of convertible notes, held by the…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
1 reverse split in 5 years (1:15 on Oct 31, 2023) · 1:15 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 1,475)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 1, 268-K ↗Current report · Communication to the market
- Aug 26, 268-K ↗Current report · Communication to the market
- Aug 7, 2610-Q ↗Quarterly report
- Aug 7, 268-K ↗Current report · Results
- Jul 16, 268-K ↗Current report · A senior executive left or was appointed
- Jul 15, 268-K/A ↗Current report · Results · amendment
- Jul 13, 26S-3/A ↗Securities offering · amendment
- Jun 23, 26S-3 ↗Securities offering
- Jun 22, 26Form 4 ↗Insider transaction
- Jun 16, 268-K ↗Current report · Shareholder vote results
1,475 filings on record, the oldest from Apr 11, 06.
Listing the 25 most recent filings of the 1,475 on record.
137280
- Jul 16, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 4, 26Completed an acquisition or disposal+6 more in the same filing8-K 2.01 ↗
- Apr 17, 26Entered a material agreement+1 more in the same filing8-K/A 1.01 ↗
- Mar 2, 26Entered a material agreement+5 more in the same filing8-K 1.01 ↗
- Aug 22, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 11, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- May 23, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jan 6, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 27, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Aug 8, 24A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Jul 5, 24Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Mar 26, 24Listing notice (8-K 3.01)8-K 3.01 ↗
7 older filings not shown · The record reaches back to Jun 27, 06.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jan 19, 24Listing notice (8-K 3.01)+2 more in the same filing8-K/A 3.01 ↗
- May 5, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 7, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 4, 22Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 5, 22Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Feb 18, 22Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 12, 21Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Dec 2, 16Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 13 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- GNI USA, Inc.69.1%May 4, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Ying Luo8.6%May 4, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Songjiang Ma6.3%May 4, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Jun 18, 26Sell$19KWeiguo YeChief Operating Officer↗
- Jun 11, 26Sell$17KWeiguo YeChief Operating Officer↗
- Jun 10, 26Sell$40KWeiguo YeChief Operating Officer↗
- Jun 10, 26Sell$31KWeiguo YeChief Operating Officer↗
- Jun 9, 26Sell$89KWeiguo YeChief Operating Officer↗
- Jun 9, 26Sell$18KWeiguo YeChief Operating Officer↗
- Jun 5, 26Sell$99KWeiguo YeChief Operating Officer↗
- Jun 4, 26Sell$120KWeiguo YeChief Operating Officer↗
- May 26, 26Sell$24KWeiguo YeChief Operating Officer↗
- May 22, 26Sell$21KWeiguo YeChief Operating Officer↗
- May 21, 26Sell$79KWeiguo YeChief Operating Officer↗
- May 20, 26Sell$58KWeiguo YeChief Operating Officer↗
There are 12 more transactions in this stretch.
Stock compensation, tax and giftsshow the 16 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 18, 26Compensation$2KWeiguo YeChief Operating Officer↗
- Jun 11, 26Compensation$2KWeiguo YeChief Operating Officer↗
- Jun 10, 26Compensation$5KWeiguo YeChief Operating Officer↗
- Jun 10, 26Compensation$4KWeiguo YeChief Operating Officer↗
- Jun 9, 26Compensation$11KWeiguo YeChief Operating Officer↗
- Jun 9, 26Compensation$2KWeiguo YeChief Operating Officer↗
- Jun 5, 26Compensation$12KWeiguo YeChief Operating Officer↗
- Jun 4, 26Compensation$15KWeiguo YeChief Operating Officer↗
- May 26, 26Compensation$3KWeiguo YeChief Operating Officer↗
- May 22, 26Compensation$3KWeiguo YeChief Operating Officer↗
- May 21, 26Compensation$10KWeiguo YeChief Operating Officer↗
- May 20, 26Compensation$7KWeiguo YeChief Operating Officer↗
- May 19, 26Compensation$7KWeiguo YeChief Operating Officer↗
- May 18, 26Compensation$150Weiguo YeChief Operating Officer↗
- May 15, 26Compensation$10KWeiguo YeChief Operating Officer↗
- May 14, 26Compensation$12KWeiguo YeChief Operating Officer↗
The full record holds 147 transactions and goes back to Dec 26, 22.
Its sector and its market
Gyre Therapeutics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Gyre Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Gyre Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,475 documents on file, from Apr 11, 2006 to Sep 1, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.